WH, Bromley PG, Vittorio CC, Rook AH: Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution. Archives of Dermatology. 138(8):1054-1060, 2002.

Lehrer MS, Crawford GH, Gelfand JM, Leyden JJ, Vittorio CC: Effect of wax epilation before hair removal with a long-pulsed alexandrite laser: a pilot study. Dermatologic Surgery. 29(2):118-122, 2003.

Prins C, Vittorio C, Padilla RS, Hunziker T, Itin P, Forster J, Brocker EB, Saurat JH, French LE: Effect of high-dose intravenous immunoglobulin therapy in Stevens-Johnson syndrome: a retrospective, multicenter study. Dermatology. 207(1):96-99, 2003.

Shapiro M, Wasik MA, Junkins-Hopkins JM, Rook AH, Vittorio CC, Itakura H, Frankel MC, Georgala S, Schuster SJ: Complete remission in advanced blastic NK-cell lymphoma/leukemia in elderly patients using the hyper-CVAD regimen. American Journal of Hematology. 74(1):46-51, 2003.

McGinnis KS, Shapiro M, Vittorio CC, Rook AH, Junkins-Hopkins JM: Psoralen plus long-wave UV-A(PUVA) and bexarotene therapy: An effective and synergistic combined adjunct to therapy for patients with advanced cutaneous T-cell lymphoma. Archives of Dermatology. 139(6):771-775, 2003.

McGinnis KS, Junkins-Hopkins JM, Crawford G, Shaporo M, Rook AH, Vittorio CC: Low-dose oral bexarotene in combination with low-dose interferon alfa in the treatment of cutaneous T-cell lymphoma: clinical synergism and possible immunologic mechanisms. Journal of the American Academy of Dermatology. 50(3):375-379, 2004.

Gelfand JM, Wasik MA, Vittorio C, Rook A, Junkins-Hopkins JM: Progressive epidermotropic CD8+/CD4- primary cutaneous CD30+ lymphoproliferative disorder in a patient with sarcoidosis. Journal of the American Academy of Dermatology. 51(2):304-308, 2004.

Richardson SK, Budgin JB, Junkins-Hopkins JM, Vittorio CC, Lee J, Miller Jr. WT, Rook AH, Kim EJ: Low-dose bexarotene and low-dose interferon alfa-2b for adult T-cell leukemia/lymphoma associated with human t-lymphotropic virus 1. Archives of Dermatology. 141(3):301-304, 2005.

Junkins-Hopkins JM, Rook AH, Vittorio CC: Lymphomatoid Papulosis. In: Treatment of Skin Disease. Lebwohl M, Heymann W, Berth-Jones J, Coulson I. (Eds.), Mosby International Limited, London, 2002.

McDonald CJ, Muglia JJ, Vittorio CC: Alopecia and Cutaneous Complications. In Clincal Oncology, 2nd Edition, WB Saunders Co., New York, NY, 2000.

Vittorio CC, Junkins-Hopkins JM, McGinnis KS, Shapiro M, Wysocka M, Zaki MH, French LE, Rook AH: New Biologic agents for the treatment of cutaneous T-cell lymphoma. Recent Results in Cancer Research. 160:321-328, 2002.

Rook AH, Junkins-Hopkins JM, McGinnis KS, Wysocka M, Rickardson SK, Budgin JB, Everitts S, Vittorio CC: Cytokines and other biologic agents as immunotherapeutics for cutaneous T-cell lymphoma. Advances in Dermatology. 18:29-43, 2002.

Vittorio CC, Lehrer MS: Laser hair removal. Facial Plastic Surgery. 19(1):131-136, 2003.

Rook AH, McGinnis KS, Richardson SK, Budgin JB, Wysocka M, Benoit BM, Junkins-Hopkins JM, Vittorio CC: The use of cytokines, fusion proteins and antibodies to treat cutaneous T-cell lymphoma. Dermatologic Therapy. 16(4):331-336, 2003.

Richardson SK, McGinnis KS, Shapiro M, Lehrer MS, Kim EJ, Vittorio CC, Junkins-Hopkins JM, Rook AH: Extracorporeal photopheresis and multimodality immunomodulatory therapy in the treatment of cutaneous T-cell lymphoma. Journal of Cutaneous Medicine and Surgery. [E-pub], Sep 9, 2003.

Kim EJ, Hess S, Richardson SK, Newton S, Showe LC, Benoit BM, Ubriani R, Vittorio CC, Junkins-Hopkins JM, Wysocka M, Rook AH: Immunopathogenesis and therapy of cutaneous T-cell lymphoma. Journal of clinical Investigation. 115:798-812, 2005.